HomeDRMA • NASDAQ
Dermata Therapeutics Inc
add
$0.69
1.91%
After Hours:(1.31%)-0.0091
$0.69
Closed: Jun 18, 6:55:46 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.34M | -26.96% |
Net income | -2.30M | 26.50% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.72M | 105.32% |
Total assets | 10.01M | 93.16% |
Total liabilities | 2.70M | 97.10% |
Total equity | 7.30M | — |
Shares outstanding | 6.38M | — |
Price to book | 0.58 | — |
Return on assets | -86.41% | — |
Return on capital | -132.01% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.30M | 26.50% |
Cash from operations | -1.93M | 28.49% |
Cash from investing | — | — |
Cash from financing | 8.49M | — |
Net change in cash | 6.56M | 342.48% |
Free cash flow | -607.62K | 61.36% |
Previous close
$0.71
Day range
$0.65 - $0.72
Year range
$0.65 - $5.00
Market cap
4.41M USD
Avg Volume
105.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
8